Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F12%3A33152304" target="_blank" >RIV/61989592:15110/12:33152304 - isvavai.cz</a>

Výsledek na webu

<a href="http://dx.doi.org/10.1136/annrheumdis-2011-200631" target="_blank" >http://dx.doi.org/10.1136/annrheumdis-2011-200631</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1136/annrheumdis-2011-200631" target="_blank" >10.1136/annrheumdis-2011-200631</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry

Popis výsledku v původním jazyce

The Digital Ulcers Outcome (DUO) Registry was designed to describe the clinical and antibody characteristics, disease course and outcomes of patients with digital ulcers associated with systemic sclerosis (SSc). The DUO Registry is a European, prospective, multicentre, observational, registry of SSc patients with ongoing digital ulcers disease, irrespective of treatment regimen. Data collected included demographics, SSc duration, SSc subset, internal organ manifestations, autoantibodies, previous and ongoing interventions and complications related to didital ulcers. Up to 19 Novečmber 2010 a total of 2439 patients had enrolled into the registry. Most were classified as either limited cutaneous SSc (IcSSc; 52,2%) of diffuse cutaneous SSc (DcSSc; 36,9%).Digital ulcers developer earlier in patients with dcSSc compared with IcSSc. Almost all patients (95.7%) tested positive for antinuclear antibodies, 45,2% for anti-scleroderma-70 and 43,6% for anticentromere antibodies (ACA). The first di

Název v anglickém jazyce

Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry

Popis výsledku anglicky

The Digital Ulcers Outcome (DUO) Registry was designed to describe the clinical and antibody characteristics, disease course and outcomes of patients with digital ulcers associated with systemic sclerosis (SSc). The DUO Registry is a European, prospective, multicentre, observational, registry of SSc patients with ongoing digital ulcers disease, irrespective of treatment regimen. Data collected included demographics, SSc duration, SSc subset, internal organ manifestations, autoantibodies, previous and ongoing interventions and complications related to didital ulcers. Up to 19 Novečmber 2010 a total of 2439 patients had enrolled into the registry. Most were classified as either limited cutaneous SSc (IcSSc; 52,2%) of diffuse cutaneous SSc (DcSSc; 36,9%).Digital ulcers developer earlier in patients with dcSSc compared with IcSSc. Almost all patients (95.7%) tested positive for antinuclear antibodies, 45,2% for anti-scleroderma-70 and 43,6% for anticentromere antibodies (ACA). The first di

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FP - Ostatní lékařské obory

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2012

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Annals of the Rheumatic Diseases

ISSN

0003-4967

e-ISSN

—

Svazek periodika

71

Číslo periodika v rámci svazku

5

Stát vydavatele periodika

GB - Spojené království Velké Británie a Severního Irska

Počet stran výsledku

4

Strana od-do

718-721

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—